The issue of Supriya Lifescience Limited, was subscribed 71.51 times due to the strong demand from investors by the end of the day. The quota for non-institutional investors was subscribed 161 times. (Pixabay)
1/4 The issue of Supriya Lifescience Limited, was subscribed 71.51 times due to the strong demand from investors by the end of the day. The quota for non-institutional investors was subscribed 161 times. (Pixabay)
Bidders can expect the share allotment announcement by tomorrow, that is December 23. Subscribers can check the application status on Bombay Stock Exchange (BSE) through this link - https://www.bseindia.com/investors/appli_check.aspx and Link Intime India Private Limited via this link - https://linkintime.co.in/MIPO/Ipoallotment.html. (Supriya Lifescience)
2/4 Bidders can expect the share allotment announcement by tomorrow, that is December 23. Subscribers can check the application status on Bombay Stock Exchange (BSE) through this link - https://www.bseindia.com/investors/appli_check.aspx and Link Intime India Private Limited via this link - https://linkintime.co.in/MIPO/Ipoallotment.html. (Supriya Lifescience)
Supriya Lifescience’s GMP value is commanding at ₹130 in the grey market today, IPO Watch data showed. (Pixabay )
3/4 Supriya Lifescience’s GMP value is commanding at ₹130 in the grey market today, IPO Watch data showed. (Pixabay )
Talking about the Supriya Lifescience, it was founded in 2008, had 38 APIs as of October, with an emphasis on antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic, and anti-allergic segments. (Pixabay)
4/4 Talking about the Supriya Lifescience, it was founded in 2008, had 38 APIs as of October, with an emphasis on antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic, and anti-allergic segments. (Pixabay)